Marinomed Biotech AG
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 52
- Market Cap
- -
- Website
- http://www.marinomed.com
Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 30
- Registration Number
- NCT06262100
- Locations
- 🇪🇸
IOBA,Ocular Surface Research Group, University of Valladolid, Valladolid, Spain
Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 14
- Registration Number
- NCT04793984
- Locations
- 🇦🇹
Gesundheitsverbund, Klinik Floridsdorf, Vienna, Austria
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 300
- Registration Number
- NCT04681001
- Locations
- 🇦🇹
Gesundheitsverbund, Klinik Favoriten, Vienna, Austria
🇦🇹Gesundheitsverbund Klinik Floridsdorf, Vienna, Austria
Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 29
- Registration Number
- NCT04533906
- Locations
- 🇦🇹
Dr. Friedrich Ehrenreich, Vienna, Austria
Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 64
- Registration Number
- NCT04532710
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 42
- Registration Number
- NCT04532762
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 42
- Registration Number
- NCT04531358
- Locations
- 🇦🇹
Ordination Dr. Petra Zieglmayer Vienna Challenge Chamber, Vienna, Austria
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 82
- Registration Number
- NCT03755557
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
© Copyright 2024. All Rights Reserved by MedPath